CVS Caremark (CVS) Tops Q1 EPS by 2c; Boosts FY12 adj.-EPS Outlook; Guides Q2
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $94.01 -3.24%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) reported Q1 EPS of $0.65, $0.02 better than the analyst estimate of $0.63. Revenue for the quarter came in at $30.8 million versus the consensus estimate of $30.31 billion.
Retail Pharmacy segment same stores sales increased 8.4%.
CVS Caremark sees FY2012 EPS of $3.23-$3.33, versus the consensus of $3.27.
CVS Caremark sees Q2 2012 EPS of $0.78-$0.80, versus the consensus of $0.74.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Retail Pharmacy segment same stores sales increased 8.4%.
CVS Caremark sees FY2012 EPS of $3.23-$3.33, versus the consensus of $3.27.
CVS Caremark sees Q2 2012 EPS of $0.78-$0.80, versus the consensus of $0.74.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Limoneira sells vineyard property for $15M at public auction
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
